Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-10T21:37:01.278Z Has data issue: false hasContentIssue false
  • English
  • Français

Question-and-Answer Session

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Expert Roundtable Supplement
Information
CNS Spectrums , Volume 12 , Issue S21: Inpatient to Outpatient Status: Clinical Considerations in the Transitional Treatment of Schizophrenia , December 2007 , pp. 18
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Weiden, PJ, Mackell, JA, McDonnell, DD. Obesity as a risk factor for antipsychotic non-compliance. Schizophr Res. 2004;66(1):51–57.Google Scholar
2.Bradford, LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002;3(2):229–243.Google Scholar
3.Bradford, LD, Gaedigk, A, et al.High frequency of CYP2D6 poor and “intermediate” metabolizers in black populations: a review and preliminary data. Psychopharmacol Bull. 1998;34(4):797–804.Google ScholarPubMed